Kopran
Kopran Share Price Chart
Kopran last traded at ₹261.15 (2026-10-13). Over the past month the stock moved +10.0%, three months the stock moved +34.6%, year the stock moved +51.0%. Its closing range over 52 weeks is ₹113.50 – ₹290.50, with the latest close 10.1% below the high.
Closing prices up to 2026-10-13.
About Kopran
Kopran Ltd. is a fully integrated pharmaceutical company that manufactures and supplies high-quality formulations and active pharmaceutical ingredients globally.
Business Verticals: A) API:[1] It is operated through Kopran Research Laboratories Ltd. (KRLL), a wholly owned subsidiary of Kopran Limited Product Categories:[1] Atenolol, Cephalosporins (Non-sterile & Sterile), Macrolides, Granules, Sterile Carbapenems, Multipurpose products. Product Segments:[1] Anti-hypertensive, Macrolide, Neuromodulator, Urological, Anti-infective / Anti-acne, Sterile Carbapenem, Sterile Cephalosporin, Anti-thrombotic, Intermediate, Anti-Diabetic, Cardiology, NSAIDs, Anti-Lipid. Manufacturing:[1] The facility is located at MIDC Mahad, with an area of 11,900 sq. mt and has 26 products commercialised.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Kopran reported sales of ₹153.99 crore (+13.9%) and net profit of ₹6.70 crore (-10.1%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 153.99 | 15.81 | 10.27 | 6.70 | 1.39 |
| Mar 2026 | 234.02 | 32.94 | 14.08 | 18.87 | 3.91 |
| Dec 2025 | 194.28 | 17.76 | 9.14 | 9.34 | 1.94 |
| Sep 2025 | 117.91 | -5.28 | -4.48 | -9.92 | -2.06 |
| Jun 2025 | 135.22 | 14.13 | 10.45 | 7.45 | 1.54 |
| Mar 2025 | 172.36 | 17.09 | 9.92 | 9.68 | 2.01 |
| Dec 2024 | 166.24 | 19.85 | 11.94 | 10.40 | 2.16 |
| Sep 2024 | 151.56 | 14.73 | 9.72 | 7.38 | 1.53 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -0.7% | +4.6% | -7.4% | -3.0% | -22.2% | +16.9% | +35.8% | +13.9% |
| Operating profit growth | -35.5% | -15.8% | -21.2% | -22.2% | -135.8% | -10.5% | +92.7% | +11.9% |
| Net profit growth | -46.4% | -34.1% | -48.0% | -32.9% | -234.4% | -10.2% | +94.9% | -10.1% |
| EPS growth | -46.5% | -34.1% | -47.9% | -33.0% | -234.6% | -10.2% | +94.5% | -9.7% |
| OPM % | 9.7% | 11.9% | 9.9% | 10.5% | -4.5% | 9.1% | 14.1% | 10.3% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Kopran reported sales of ₹681.00 crore (+8.1%) and net profit of ₹26.00 crore (-33.3%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 681.00 | 62.00 | 9.00 | 26.00 | 5.33 |
| Mar 2025 | 630.00 | 73.00 | 12.00 | 39.00 | 7.99 |
| Mar 2024 | 615.00 | 74.00 | 12.00 | 51.00 | 10.57 |
| Mar 2023 | 551.00 | 52.00 | 9.00 | 27.00 | 5.65 |
| Mar 2022 | 478.00 | 87.00 | 18.00 | 61.00 | 12.66 |
| Mar 2021 | 492.00 | 82.00 | 17.00 | 62.00 | 14.24 |
| Mar 2020 | 360.00 | 47.00 | 13.00 | 21.00 | 4.86 |
| Mar 2019 | 358.00 | 46.00 | 13.00 | 24.00 | 5.55 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +14.4% | +0.6% | +36.7% | -2.8% | +15.3% | +11.6% | +2.4% | +8.1% |
| Operating profit growth | +48.4% | +2.2% | +74.5% | +6.1% | -40.2% | +42.3% | -1.4% | -15.1% |
| Net profit growth | +20.0% | -12.5% | +195.2% | -1.6% | -55.7% | +88.9% | -23.5% | -33.3% |
| EPS growth | +17.1% | -12.4% | +193.0% | -11.1% | -55.4% | +87.1% | -24.4% | -33.3% |
| OPM % | 13.0% | 13.0% | 17.0% | 18.0% | 9.0% | 12.0% | 12.0% | 9.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Kopran.
Get Free AI Stock Analysis FREE →Latest News
-
Kopran consolidated net profit declines 10.07% in the June 2026 quarter - Business Standard
-
Kopran consolidated net profit declines 10.07% in the June 2026 quarter - business-standard.com
-
Kopran Ltd Hits Lower Circuit Amid Heavy Selling Pressure and Panic Selling
-
Kopran Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility
Frequently Asked Questions
What is the share price of Kopran today?
Kopran shares were last quoted at ₹261.15 (+4.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Kopran?
Kopran has a price-to-earnings (P/E) ratio of 55.10 and a price-to-book (P/B) ratio of 2.56. The industry P/E is 53.33.
What is the 52-week high and low of Kopran?
The 52-week high of Kopran is ₹287.60 and the 52-week low is ₹107.00.
What is the market cap of Kopran?
The market capitalisation of Kopran is about ₹1,376.57 crore.
How did Kopran perform in its latest quarterly results?
In the latest quarter (Jun 2026), Kopran reported sales of ₹153.99 crore (+13.9%) and net profit of ₹6.70 crore (-10.1%), compared with the same quarter last year.
Is Kopran a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Kopran has a 3-year ROE of 8.00%, 3-year profit growth of -2.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Kopran?
Promoters hold about 44.42% of Kopran.
Which sector does Kopran belong to?
Kopran belongs to the Pharmaceuticals & Drugs sector.